Trigeminal neuralgia
ICD-10 G50.0 · ICD-11 8B82.0

Intravenous Infusion Treatment for Trigeminal Neuralgia Requiring Hospital Admission

This first-line protocol covers trigeminal neuralgia (ICD-11 8B82.0 / ICD-10 G50.0) in patients managed with a hospital-admitted, fully monitored intravenous approach.

Treatment approach Management involves intravenous infusion therapy administered under hospital admission with full clinical monitoring — the complete agent selection and dosing protocol is available via the link below.
Instant Access to Structured Evidence-Based Regimens

References

  • Lidocaine infusion – 1.5mg/kg intravenous infusion over 1 hour (hospital admission with full monitoring; in 2020 the UK lidocaine infusion safety group published a recommendation for a reduced dosage of lidocaine (from 5mg down to 1.5mg/kg) subject to a review of efficacy)
  • Fosphenytoin – 15mg/kg intravenous infusion (hospital admission with full monitoring)
  • Phenytoin – 10mg/kg intravenous infusion (hospital admission with full monitoring)
View source ↗